X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB AJANTA PHARMA UNICHEM LAB/
AJANTA PHARMA
 
P/E (TTM) x -276.4 19.5 - View Chart
P/BV x 2.0 4.5 45.4% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 UNICHEM LAB   AJANTA PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-17
AJANTA PHARMA
Mar-18
UNICHEM LAB/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3201,818 17.6%   
Low Rs2211,106 20.0%   
Sales per share (Unadj.) Rs167.2239.5 69.8%  
Earnings per share (Unadj.) Rs12.052.8 22.7%  
Cash flow per share (Unadj.) Rs16.959.5 28.5%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs117.0230.0 50.9%  
Shares outstanding (eoy) m90.8888.77 102.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.66.1 26.5%   
Avg P/E ratio x22.627.7 81.7%  
P/CF ratio (eoy) x16.024.6 65.0%  
Price / Book Value ratio x2.36.4 36.3%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m24,578129,782 18.9%   
No. of employees `0005.26.8 76.4%   
Total wages/salary Rs m2,4873,765 66.1%   
Avg. sales/employee Rs Th2,928.33,128.4 93.6%   
Avg. wages/employee Rs Th479.4554.0 86.5%   
Avg. net profit/employee Rs Th209.4689.7 30.4%   
INCOME DATA
Net Sales Rs m15,19521,258 71.5%  
Other income Rs m110242 45.6%   
Total revenues Rs m15,30521,499 71.2%   
Gross profit Rs m1,7886,584 27.2%  
Depreciation Rs m452596 75.8%   
Interest Rs m344 822.0%   
Profit before tax Rs m1,4136,226 22.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3261,539 21.2%   
Profit after tax Rs m1,0874,686 23.2%  
Gross profit margin %11.831.0 38.0%  
Effective tax rate %23.124.7 93.3%   
Net profit margin %7.222.0 32.4%  
BALANCE SHEET DATA
Current assets Rs m6,42612,236 52.5%   
Current liabilities Rs m3,9173,461 113.2%   
Net working cap to sales %16.541.3 40.0%  
Current ratio x1.63.5 46.4%  
Inventory Days Days6860 112.4%  
Debtors Days Days7784 91.1%  
Net fixed assets Rs m7,41011,140 66.5%   
Share capital Rs m182177 102.8%   
"Free" reserves Rs m10,45420,237 51.7%   
Net worth Rs m10,63620,414 52.1%   
Long term debt Rs m410 43.6%   
Total assets Rs m15,25824,486 62.3%  
Interest coverage x42.91,519.4 2.8%   
Debt to equity ratio x00 83.6%  
Sales to assets ratio x1.00.9 114.7%   
Return on assets %7.319.2 38.3%  
Return on equity %10.223.0 44.5%  
Return on capital %13.630.5 44.6%  
Exports to sales %24.10-   
Imports to sales %4.90-   
Exports (fob) Rs m3,666NA-   
Imports (cif) Rs m752NA-   
Fx inflow Rs m5,29811,667 45.4%   
Fx outflow Rs m01,616 0.0%   
Net fx Rs m5,29810,052 52.7%   
CASH FLOW
From Operations Rs m6832,854 23.9%  
From Investments Rs m-1,316-2,604 50.5%  
From Financial Activity Rs m592-2 -29,610.0%  
Net Cashflow Rs m-40248 -16.1%  

Share Holding

Indian Promoters % 50.1 73.8 67.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 1.6 974.2%  
FIIs % 3.0 7.6 39.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 17.0 186.5%  
Shareholders   20,176 20,968 96.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   CIPLA  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 219 Points Lower; Energy and Auto Stocks Witness Selling(Closing)

After witnessing volatile trades during the day, Indian share markets ended their session on a negative note. Losses were largely seen in the oil & gas sector, auto sector.

Related Views on News

UNICHEM LAB Announces Quarterly Results (4QFY18); Net Profit Down 91.1%

Jun 14, 2018 | Updated on Jun 14, 2018

For the quarter ended March 2018, UNICHEM LAB has posted a net profit of Rs 28 m (down 91.1% YoY). Sales on the other hand came in at Rs 2 bn (down 40.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

This Behaviour is Injurious to Wealth Building(Sector Info)

Jun 13, 2018

Blindly following the herd can be the biggest wealth destroyer.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Jun 25, 2018 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS